Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Xandra Owens Breakefield, Ph.D.

Co-Author

This page shows the publications co-authored by Xandra Breakefield and Casey Maguire.
Connection Strength

2.295
  1. Gene therapy for the nervous system: challenges and new strategies. Neurotherapeutics. 2014 Oct; 11(4):817-39.
    View in: PubMed
    Score: 0.609
  2. Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin. Sci Adv. 2021 Jan; 7(2).
    View in: PubMed
    Score: 0.235
  3. Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1. Mol Ther Methods Clin Dev. 2019 Dec 13; 15:18-26.
    View in: PubMed
    Score: 0.213
  4. Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV. Mol Ther. 2017 02 01; 25(2):379-391.
    View in: PubMed
    Score: 0.178
  5. Extracellular vesicles and intercellular communication within the nervous system. J Clin Invest. 2016 Apr 01; 126(4):1198-207.
    View in: PubMed
    Score: 0.169
  6. Heparin affinity purification of extracellular vesicles. Sci Rep. 2015 May 19; 5:10266.
    View in: PubMed
    Score: 0.159
  7. Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. ACS Nano. 2014 Jan 28; 8(1):483-494.
    View in: PubMed
    Score: 0.145
  8. Heparin blocks transfer of extracellular vesicles between donor and recipient cells. J Neurooncol. 2013 Dec; 115(3):343-51.
    View in: PubMed
    Score: 0.141
  9. Microvesicle-associated AAV vector as a novel gene delivery system. Mol Ther. 2012 May; 20(5):960-71.
    View in: PubMed
    Score: 0.127
  10. Preventing growth of brain tumors by creating a zone of resistance. Mol Ther. 2008 Oct; 16(10):1695-702.
    View in: PubMed
    Score: 0.100
  11. High levels of AAV vector integration into CRISPR-induced DNA breaks. Nat Commun. 2019 09 30; 10(1):4439.
    View in: PubMed
    Score: 0.054
  12. CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease. Mol Ther Nucleic Acids. 2018 Jun 01; 11:429-440.
    View in: PubMed
    Score: 0.048
  13. Viral vectors for therapy of neurologic diseases. Neuropharmacology. 2017 Jul 01; 120:63-80.
    View in: PubMed
    Score: 0.042
  14. Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy. Mol Ther. 2015 May; 23(5):824-834.
    View in: PubMed
    Score: 0.039
  15. BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. Mol Ther Nucleic Acids. 2013 Jul 23; 2:e109.
    View in: PubMed
    Score: 0.035
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.